BEGIN:VCALENDAR
CALSCALE:GREGORIAN
X-WR-TIMEZONE;VALUE=TEXT:US/Central
PRODID:-//Apple Computer\, Inc//iCal 1.0//EN
X-WR-RELCALID;VALUE=TEXT:BECEF804-5047-11D7-83A9-00039357ED28-CALP
X-WR-CALNAME;VALUE=TEXT:Reproductive
VERSION:2.0
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Chronic Illness & Death in Children
DTSTART;TZID=US/Central:20020917T080000
UID:BFA0412C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Impact of AIDS
DTSTART;TZID=US/Central:20020917T090000
UID:BFA04C58-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Death & Dying
DTSTART;TZID=US/Central:20020919T100000
UID:BFA051C6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Myers Briggs Test
DTSTART;TZID=US/Central:20020919T130000
UID:BFA055F1-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Neurology of Behavior
DTSTART;TZID=US/Central:20020926T100000
UID:BFA05A20-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Ethics
DTSTART;TZID=US/Central:20020926T130000
UID:BFA05E21-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Physician Health & Impairment
DTSTART;TZID=US/Central:20020926T140000
UID:BFA06268-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Sleep
DTSTART;TZID=US/Central:20021003T100000
UID:BFA06690-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Myers-Briggs Interpretation
DTSTART;TZID=US/Central:20021003T110000
UID:BFA06AE0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Behavioral Genetics
DTSTART;TZID=US/Central:20021003T130000
UID:BFA06EFE-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Review
DTSTART;TZID=US/Central:20021009T150000
UID:BFA07354-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:BS: Final Exam
DTSTART;TZID=US/Central:20021017T090000
UID:BFA07773-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Principles of Otolaryngology
DTSTART;TZID=US/Central:20020913T080000
UID:BFA07B66-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Hearing Loss & Ear Disease
DTSTART;TZID=US/Central:20020913T090000
UID:BFA07F4E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Otolaryngic Emergencies
DTSTART;TZID=US/Central:20020913T100000
UID:BFA08366-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Cystic Fibrosis
DTSTART;TZID=US/Central:20020913T110000
UID:BFA08766-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Chest Disease
DTSTART;TZID=US/Central:20020913T130000
UID:BFA08B70-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Anatomy Review
DTSTART;TZID=US/Central:20020916T080000
UID:BFA08FCA-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Respiratory Phys. & Pulmonary Fnctn. Testing
DTSTART;TZID=US/Central:20020916T090000
UID:BFA0940E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: How Kids Breathe
DTSTART;TZID=US/Central:20020916T100000
UID:BFA097F5-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Radiologic Studies of the Chest
DTSTART;TZID=US/Central:20020916T110000
UID:BFA09C1A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Penicillins
DTSTART;TZID=US/Central:20020917T150000
UID:BFA0A070-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: General Considerations
DTSTART;TZID=US/Central:20020917T140000
UID:BFA0A4BA-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Cephalosporins
DTSTART;TZID=US/Central:20020918T140000
UID:BFA0A90A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Tetracyclines
DTSTART;TZID=US/Central:20020918T150000
UID:BFA0B3A6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Lab Groups 1\, 15\, 16\, 17
DTSTART;TZID=US/Central:20020916T130000
UID:BFA0B9D0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Lab Groups 3\, 4\, 13\, 14
DTSTART;TZID=US/Central:20020920T130000
UID:BFA0BE28-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Lab 12\, 18\, 19\, 20
DTSTART;TZID=US/Central:20020923T130000
UID:BFA0C2A6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Lab Groups 2\, 5\, 6\, 7
DTSTART;TZID=US/Central:20020930T130000
UID:BFA0C6C9-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Lab Groups 8\, 9\, 10\, 11
DTSTART;TZID=US/Central:20021009T090000
UID:BFA0CAD0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: ID Intro
DTSTART;TZID=US/Central:20020918T130000
UID:BFA0CEE2-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Aminoglycosides\, etc.
DTSTART;TZID=US/Central:20020919T080000
UID:BFA0D2D0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Clinical Aspects of Antibiotic Use
DTSTART;TZID=US/Central:20020919T090000
UID:BFA0DBD0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pleural Effusions
DTSTART;TZID=US/Central:20020920T090000
UID:BFA0E09A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Respiratory Physiology in Pregnancy
DTSTART;TZID=US/Central:20020920T100000
UID:BFA0E4A4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pulmonary Transition to Postnatal Life
DTSTART;TZID=US/Central:20020920T110000
UID:BFA0E8E5-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antifungal\, Antiviral\, Anthelmintic\, etc
DTSTART;TZID=US/Central:20020923T100000
UID:BFA0ECDB-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: AntiTB\, Antilepromatous\, Antimalarial
DTSTART;TZID=US/Central:20020923T110000
UID:BFA0F10A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 1
DTSTART;TZID=US/Central:20020924T130000
UID:BFA0F524-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Interstitial Lung Disease
DTSTART;TZID=US/Central:20020925T130000
UID:BFA0F954-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Inhalational Lung Diseases
DTSTART;TZID=US/Central:20020925T140000
UID:BFA0FD72-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 1
DTEND;TZID=US/Central:20020927T100000
DTSTART;TZID=US/Central:20020927T080000
UID:BFA1017F-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Immunologic Disorders of the Lung
DTSTART;TZID=US/Central:20020926T080000
UID:BFA10584-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Review of Drugs to date
UID:BFA1096C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20020926T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 2
DTSTART;TZID=US/Central:20020927T130000
UID:BFA10D5B-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Bronchopulmonary Dysplasia & Asthma
DTEND;TZID=US/Central:20020930T100000
DTSTART;TZID=US/Central:20020930T080000
UID:BFA1112D-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Atelectasis & COPD
DTSTART;TZID=US/Central:20020930T100000
UID:BFA1150C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Respiratory Pharm
DTSTART;TZID=US/Central:20020930T110000
UID:BFA1190A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 3
DTSTART;TZID=US/Central:20021001T130000
UID:BFA11D23-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pulmonary Conf 1
DTSTART;TZID=US/Central:20021003T080000
UID:BFA12123-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 2
DTSTART;TZID=US/Central:20021004T080000
UID:BFA1252C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 4
DTSTART;TZID=US/Central:20021004T100000
UID:BFA12946-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Acute Resp Failure
DTSTART;TZID=US/Central:20021007T080000
UID:BFA12D3C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Pulmonary Vascular Disease
DTSTART;TZID=US/Central:20021007T090000
UID:BFA1333F-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lung & Pleural Primary Neoplasms
DTSTART;TZID=US/Central:20021007T100000
UID:BFA137B0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Lung Cancer
DTSTART;TZID=US/Central:20021007T110000
UID:BFA13BC7-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 5
DTSTART;TZID=US/Central:20021007T130000
UID:BFA13FC0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 6
DTSTART;TZID=US/Central:20021009T130000
UID:BFA143A9-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 3
DTSTART;TZID=US/Central:20021010T080000
UID:BFA147A9-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pulmonary Conf 2
DTSTART;TZID=US/Central:20021010T100000
UID:BFA14B96-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Infection in the Newborn
DTSTART;TZID=US/Central:20021011T100000
UID:BFA14FB4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Bioterrorism
DTSTART;TZID=US/Central:20021011T110000
UID:BFA15394-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 7
DTSTART;TZID=US/Central:20021011T130000
UID:BFA15794-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conf ID 8
DTSTART;TZID=US/Central:20021014T100000
UID:BFA15BBC-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: ID Review
DTSTART;TZID=US/Central:20021015T100000
UID:BFA15FDC-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pulmonary Depression
DTSTART;TZID=US/Central:20021015T110000
UID:BFA163CE-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:PULMONARY Module Exam
DTSTART;TZID=US/Central:20021021T090000
UID:BFA167F1-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Acute Pulmonary Infections
UID:BFA16BF8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20020923T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Granulomatous Pulmonary Diseases
UID:BFA17007-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20020923T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Infectious Disease Exam
UID:BFA17423-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021023T090000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Intro to Cardiology
UID:BFA1855A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021024T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Physiology
UID:BFA1899E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021024T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Cardiac lecture (mandatory)
UID:BFA18DA5-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021024T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pediatric Cardiac Examination
UID:BFA191FB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021025T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Special Tests & Procedures
UID:BFA195DF-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021025T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Intro to Congenital Heart Disease I
UID:BFA199D5-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021025T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Intro to Congenital Heart Disease II
UID:BFA19DBB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021025T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Congenital Heart Disease in Adults
UID:BFA1A192-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021028T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Hyperlipidemia
UID:BFA1A5BA-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021028T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antilipemic Drugs
UID:BFA1A9F8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021028T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Athersclerosis
UID:BFA1ADE6-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021028T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Coronary Artery Disease I
UID:BFA1B1BB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021028T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antianginal Drugs
UID:BFA1B5AB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021029T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Myocardial Infarction
UID:BFA1B9A1-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021029T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS:  Coronary Artery Disease II (MI)
UID:BFA1BD7B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021029T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: CAD III (Cases)
UID:BFA1C15C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021029T160000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Peripheral Vascular Disease & Vascular Aneurysms
UID:BFA21652-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021031T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Peripheral Vascular Disease
UID:BFA21C6E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021031T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 1
UID:BFA22094-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021031T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antiplatelet & Anticoagulant Drugs
UID:BFA2248A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021031T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antiplatelet & Anticoagulant Drugs
UID:BFA22899-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021031T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Valvular Heart Disease & Rheumatic Heart Disease
UID:BFA22CA6-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021031T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Cardiac Lab- Groups 3\, 9\, 10\, 11
UID:BFA23096-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021028T140000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Cardiac Lab- Groups 17\, 18\, 19\, 20
UID:BFA23845-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021030T130000
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Cardiac Lab- Groups 1\,12\,15\,16
UID:BFA23EBD-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021101T130000
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Cardiac Lab- Groups 2\, 5\, 6\, 7
UID:BFA242E2-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021104T140000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Cardiac Lab- Groups 4\,8\,13\,14
UID:BFA246EA-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021107T140000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Valvular Heart Disease I
UID:BFA24AD3-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021101T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Valvular Heart Disease II
UID:BFA24ECE-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021101T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Peripheral Vascular Disease
DTSTART;TZID=US/Central:20021101T100000
UID:BFA252F4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Myocardial & Pericardial Diseases
UID:BFA256DC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021101T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Dysrhythmias I
DTSTART;TZID=US/Central:20021104T080000
UID:BFA25AEA-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Dysrhythmias II
DTSTART;TZID=US/Central:20021104T090000
UID:BFA25F35-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Rhythm Disorders (Case Discussion)
DTSTART;TZID=US/Central:20021104T100000
UID:BFA2631E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Hypertension
UID:BFA2670F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021104T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Myocardial Diseases
UID:BFA26B0E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021106T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pericardial Diseases
UID:BFA26F32-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021106T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Treatment of Cardiac Dysrhythmias
UID:BFA27322-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021106T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Treatment of Cardiac Dysrhythmias
UID:BFA276EB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021106T160000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antihypertensive Drugs
UID:BFA27ACC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021107T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antihypertensive Drugs
UID:BFA27EE3-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021107T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Congestive Heart Failure
UID:BFA284C8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021107T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Shock
UID:BFA2892E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021107T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Physiologic Changes in Pregnancy I\; Cardiovascular & Renal 
 Systems
UID:BFA28D21-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021108T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Heart Disease\, Pre-eclampsia/Eclampsia
UID:BFA2912B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021108T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Treatment of Heart Failure I
UID:BFA29526-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021108T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Treatment of Heart Failure II
UID:BFA298FA-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021108T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Cardiovascular System Pathology Vasculitis
UID:BFA29CEB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021111T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Diseases of Veins & Lymphatics
UID:BFA2A0C8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021111T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 2
UID:BFA2A4C4-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021111T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Conference
UID:BFA2A8B6-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021111T130000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Review
UID:BFA2ACA1-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021112T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:CARDIOVASCULAR MODULE EXAM
UID:BFA2B092-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021115T090000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: WARD WEEK\; Groups 5\, 6\, 7\, & 8
UID:BFA2B48A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021029T080000
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: WARD WEEK\; Groups 9\, 10\, 11\, 12
UID:BFA2B852-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021105T080000
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Valvular Heart Disease III
UID:BFA2BC52-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021104T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm Review- Keeton: 3.104
DTEND;TZID=US/Central:20021112T110000
DTSTART;TZID=US/Central:20021112T100000
UID:BFA2C018-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm Review- Keeton: 2.038
DTSTART;TZID=US/Central:20021113T130000
UID:BFA2C420-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm Review- Keeton: 2.042
DTSTART;TZID=US/Central:20021114T130000
UID:BFA2C82C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path Lab: Make-up Quiz
DTSTART;TZID=US/Central:20021113T120000
UID:BFA2CC22-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Hematopoiesis & Bone Marrow Failure
UID:BFA2D01A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021118T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Intro & Classification of Anemia
UID:BFA2D438-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021118T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Intro & Classification of Anemia
UID:BFA2D81F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021118T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Hemolytic Anemia
UID:BFA2DC4F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021118T160000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Basic Immunohematology
UID:BFA2E021-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021119T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pediatric Oncology
UID:BFA2E3EC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021119T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Class Meeting: USMLE Preparation
UID:BFA2E7DC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021120T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Approach to Anemias
UID:BFA2EBC6-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021120T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Video- Phlebotomy
DTEND;TZID=US/Central:20021120T093000
UID:BFA2EF96-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021120T090000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 1
DTEND;TZID=US/Central:20021120T110000
UID:BFA2F370-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021120T093000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pediatric Hematology- Erythropoiesis &  its disorders in  
 the Newborn
UID:BFA2F74C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021120T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pediatric Hematology- Hemostasis &  its disorders in  the 
 Newborn
UID:BFA2FB16-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021120T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Mechanisms & Common Tests of Hemostasis
UID:BFA2FEDC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021121T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Bleeding Disorders
UID:BFA302E4-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021121T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Bleeding Disorders
UID:BFA306D7-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021122T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Pathophysiology & Genetics of Thrombotic Disorders
UID:BFA30AE4-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021122T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Diagnosis & Treatment of Thrombotic Disorders
UID:BFA30ED0-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021122T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Transfusion Therapy
UID:BFA312B6-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021122T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Benign Disorders of WBCs
UID:BFA31C22-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021125T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Approach to the Patient w/an Abnormal Blood Count
UID:BFA320FE-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021125T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Conf- Bleeding\, Thrombosis
UID:BFA324E7-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021125T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 2
DTEND;TZID=US/Central:20021125T150000
UID:BFA328C1-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021125T130000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Hematologic Changes in Pregnancy
UID:BFA32CCB-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021125T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: The Acute Leukemias: Diagnosis & Classification
UID:BFA330AC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021126T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Myoproliferatice Disorders
UID:BFA33489-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021126T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Myelodysplastic Syndromes
UID:BFA3386A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021126T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lymphocytic Disorders
UID:BFA33C2B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021126T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Approach to the Patient w/ Lymph Node Enlargement
UID:BFA3402B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021126T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lymphoma
UID:BFA343F2-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021126T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 3
DTEND;TZID=US/Central:20021202T100000
UID:BFA34C9F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021202T080000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Clinical Aspects of Cancer Chemotherapy
UID:BFA35148-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021202T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antineoplastic Drugs I
UID:BFA35543-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021202T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antineoplastic Drugs II
UID:BFA3593E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021202T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Plasma Cell Neoplasms
UID:BFA35D1A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021203T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: The Spleen & Disorders
UID:BFA36160-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021203T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Basic Structure & Function of Skin
UID:BFA3654F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021203T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Photobiology
UID:BFA3694F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021203T160000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Diagnosis of Skin Diseases
UID:BFA36D81-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021204T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Making A Dermatopathologic Diagnosis
UID:BFA37165-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021204T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Diagnosis of Common Skin Diseases I
UID:BFA3758B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021204T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Diagnosis of Common Skin Diseases II
UID:BFA37986-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021205T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Common Pediatric Dermatoses
UID:BFA37D6E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021205T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Lab 4
DTEND;TZID=US/Central:20021206T100000
UID:BFA38146-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021206T080000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Hematology/Dermatology: Module Exam
UID:BFA38536-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021212T090000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Intro to Course
UID:BFA3895C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021121T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Psychopath & Classification/ DSM IV
UID:BFA38D2C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021121T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Review of Development & Psychodynamic Theory
UID:BFA3916C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021121T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Psychiatric Interview/MSE: AMSIT
DTEND;TZID=US/Central:20021121T160000
UID:BFA39588-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021121T140000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Delirium\, Dementia & Amnestic Disorders
DTEND;TZID=US/Central:20021202T150000
UID:BFA39984-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021202T130000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Schizophrenia & Other Psychotic Disorders
UID:BFA39D6E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021205T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Schizophrenia & Other Psychotic Disorders\, cont'd
UID:BFA3A13B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021205T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Small Group Session 1: Introduction to AMSIT
UID:BFA3A538-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20021205T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Substance-Related Disorders
UID:BFA3A90B-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030109T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Substance-Related Disorders\, cont'd
UID:BFA3ACFE-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030109T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Group \"A\": Session 2
UID:BFA3B110-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030109T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Differential Diagnosis
DTEND;TZID=US/Central:20030116T120000
UID:BFA3B70E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030116T100000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Review
UID:BFA3BBA3-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030116T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"B\": Session 2
UID:BFA3C59F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030116T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psychopathology: EXAM I
UID:BFA3CA24-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030121T090000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Sleep Disorders
UID:BFA3CE04-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030123T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Adjustment Disorders/ Impulse Control Disorders
UID:BFA3D1FC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030123T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"A\": Session 3
UID:BFA3D5FC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030123T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Mood Disorders
DTEND;TZID=US/Central:20030130T120000
UID:BFA3D9ED-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030130T100000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Mood Disorders/ Electroconvulsive Therapy
UID:BFA3DDD4-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030130T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"B\": Session 3
UID:BFA3E20E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030130T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Anxiety Disorders
UID:BFA3E608-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030206T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Anxiety Disorders\, cont'd
UID:BFA3E9EA-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030206T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"A\": Session 4
UID:BFA3EDDC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030206T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Personality Disorders- Cluster A
UID:BFA3F1D2-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030212T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Personality Disorders- Cluster C
UID:BFA3F5DC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030212T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Psychiatric Treatments I
UID:BFA3F9BC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030212T150000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Personality Disorders- Cluster B
DTEND;TZID=US/Central:20030213T120000
UID:BFA3FDBE-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030213T100000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Psychiatric Treatments II
UID:BFA401B1-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030213T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"B\"- Session 4
UID:BFA405C8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030213T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych:  Differential Diagnosis
UID:BFA40AB8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030220T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Review
UID:BFA415FC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030220T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"A\"- Session 5
UID:BFA41B4F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030220T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"B\"- Session 5
UID:BFA4D9AA-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030227T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Review
UID:BFA4E008-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030228T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Second Examination
UID:BFA4E4AD-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030303T090000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Eating Disorders
UID:BFA4E8C4-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030320T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: AMSIT Revisited
UID:BFA4ECC8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030320T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Common Psychiatric Problems in Medical Practice
UID:BFA4F144-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030320T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"A\"- Sessopm 6
UID:BFA4F564-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030320T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Somatoform Disorders
UID:BFA4F98A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030327T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Dissociative Disorders
UID:BFA4FD9F-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030327T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Factitious Disorders/ Malingering
UID:BFA501C0-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030327T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"B\"- Session 6
UID:BFA505C4-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030327T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Childhood Disorders
UID:BFA509D9-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030403T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Developmental Disorders
UID:BFA50DFE-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030403T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"A\"- Session 7
UID:BFA51227-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030403T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Suicide
UID:BFA51645-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030407T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Cultual Issues in Psychiatry
UID:BFA51A42-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030407T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Sexual & Gender Identity Disorders
UID:BFA51E4A-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030407T150000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Differential Diagnosis
UID:BFA52259-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030410T100000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Review
UID:BFA52693-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030410T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psych: Group \"B\"- Session 7
UID:BFA52A9C-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030410T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Psychopathology Final Examination
UID:BFA52EAC-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030415T080000
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Approach to Oral & Maxillofacial Disorders
DTSTART;TZID=US/Central:20030106T080000
UID:BFA532C5-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: GI Pathology Oral Cavilty\, etc.
DTSTART;TZID=US/Central:20030106T090000
UID:BFA536D2-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: GI Pathology Oral Cavilty\, etc. II
DTSTART;TZID=US/Central:20030106T100000
UID:BFA53B10-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Radiographic & Endoscopic Gastroenterology
DTSTART;TZID=US/Central:20030106T110000
UID:BFA53F46-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Groups 1\, 2\, 3\, & 4
DTSTART;TZID=US/Central:20030107T080000
UID:BFA54331-5047-11D7-83A9-00039357ED28-RID
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS:
DTSTART;TZID=US/Central:20030107T130000
UID:BFA54D3F-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Non-neoplastic Diseases of the Bowel I
DTSTART;TZID=US/Central:20030107T140000
UID:BFA55301-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Non-neoplastic Diseases of the Bowel II
DTSTART;TZID=US/Central:20030107T150000
UID:BFA55726-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Non-neoplastic Diseases of the Bowel III
DTSTART;TZID=US/Central:20030107T160000
UID:BFA55B2E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Non-neoplastic Diseases of the Esophagus & Stomach I
DTSTART;TZID=US/Central:20030108T080000
UID:BFA55F9D-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Non-neoplastic Diseases of the Esophagus & Stomach II
DTSTART;TZID=US/Central:20030108T090000
UID:BFA563B4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Surgery of the GI Tract I
DTSTART;TZID=US/Central:20030108T100000
UID:BFA58DDE-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Surgery of the GI Tract II
DTSTART;TZID=US/Central:20030108T110000
UID:BFA59538-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Upper GI Bleeding & Peptic Ulcer Disease
DTSTART;TZID=US/Central:20030108T130000
UID:BFA5AEE4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Common Anorectal Disorders
DTSTART;TZID=US/Central:20030108T140000
UID:BFA5B332-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Malabsorption & Diarrhea
DTSTART;TZID=US/Central:20030109T090000
UID:BFA5B762-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Newborn Nutrition
DTSTART;TZID=US/Central:20030110T080000
UID:BFA5BB53-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Nutritional Support
DTSTART;TZID=US/Central:20030110T090000
UID:BFA5BF3E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Diarrhea & Constipation in Childhood
DTSTART;TZID=US/Central:20030110T100000
UID:BFA5C31C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: GI Disease in Childhood
DTSTART;TZID=US/Central:20030110T110000
UID:BFA5C725-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES Lab: Groups 2. 5. 6. & 7
DTSTART;TZID=US/Central:20030131T140000
UID:BFA5CB49-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES Lab: Groups 3\,4\,13 & 14
DTSTART;TZID=US/Central:20030203T140000
UID:BFA5CF2C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES Lab: Groups 1\,15\,16 & 17
DTSTART;TZID=US/Central:20030205T140000
UID:BFA5D313-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES Lab: Groups 12\,18\, 19 & 20
DTSTART;TZID=US/Central:20030210T140000
UID:BFA5D720-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:OSCE Group 1
DTSTART;TZID=US/Central:20030222T230000
UID:BFA5DAF0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Introduction to Clinical Neurology
DTSTART;TZID=US/Central:20030129T080000
UID:BFA5DEC6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Neurological Exam In Childhood
DTSTART;TZID=US/Central:20030129T090000
UID:BFA5E283-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Normal Aging
DTSTART;TZID=US/Central:20030129T100000
UID:BFA5E69E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Headache
DTSTART;TZID=US/Central:20030129T110000
UID:BFA5EA9C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES: Lecture
DTSTART;TZID=US/Central:20030129T130000
UID:BFA5EEB0-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Neuropathology General Concepts
DTSTART;TZID=US/Central:20030130T080000
UID:BFA5F2AD-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Neuropathology Infections of the CNS
DTSTART;TZID=US/Central:20030130T090000
UID:BFA5F69B-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pediatric Neurology
DTSTART;TZID=US/Central:20030131T080000
UID:BFA5FA7D-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Pediatric Neurology
DTSTART;TZID=US/Central:20030131T090000
UID:BFA5FE70-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Coma & Disorders of Consciousness
DTSTART;TZID=US/Central:20030131T100000
UID:BFA60266-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Neuropathology Malformations\, Developmental DZ\, & 
 Perinatal Brain Injury
DTSTART;TZID=US/Central:20030131T110000
UID:BFA60684-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antidepressant Drugs
DTSTART;TZID=US/Central:20030203T080000
UID:BFA60AA4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antianxiety Drugs
DTSTART;TZID=US/Central:20030203T090000
UID:BFA60EAF-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Alcohols
DTSTART;TZID=US/Central:20030203T100000
UID:BFA61292-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Neuromuscular Blocking Agents & Muscle Relaxants
DTSTART;TZID=US/Central:20030203T110000
UID:BFA6168E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Multiple Sclerosis
DTSTART;TZID=US/Central:20030203T130000
UID:BFA61A9C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Antipsychotic Drugs
DTEND;TZID=US/Central:20030204T140000
DTSTART;TZID=US/Central:20030204T130000
UID:BFA61E81-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Neuropathology Cerebrovascular DZ
DTSTART;TZID=US/Central:20030204T140000
UID:BFA62276-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Neuropathology Demyelinating & Degenerative DZ
DTSTART;TZID=US/Central:20030204T150000
UID:BFA6263F-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Seizure Disorders
DTSTART;TZID=US/Central:20030205T080000
UID:BFA62A28-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Cerebrovascular DZ I
DTSTART;TZID=US/Central:20030205T090000
UID:BFA62E0C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Cerebrovascular DZ II
DTSTART;TZID=US/Central:20030205T100000
UID:BFA631EA-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Dementia
DTSTART;TZID=US/Central:20030205T110000
UID:BFA635C4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Introduction- Analgesic/Anesthetic Agents & Local 
 Anesthetic Agents
DTSTART;TZID=US/Central:20030205T130000
UID:BFA63C65-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path Lab I
DTSTART;TZID=US/Central:20030206T080000
UID:BFA640A9-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Movement Disorders
DTSTART;TZID=US/Central:20030207T080000
UID:BFA644A7-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Drugs for Parkinson's DZ
DTSTART;TZID=US/Central:20030207T090000
UID:BFA64895-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Approach to Dementia
DTSTART;TZID=US/Central:20030207T100000
UID:BFA64C56-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Drugs for Epilepsy
DTSTART;TZID=US/Central:20030207T110000
UID:BFA65007-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: CNS Simulants
DTSTART;TZID=US/Central:20030207T130000
UID:BFA653E4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Acquired Disorders of the Spine\, Spinal Cord\, & Nerve 
 Roots
DTSTART;TZID=US/Central:20030210T080000
UID:BFA657CC-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Neuromuscular Junction Disorders
DTSTART;TZID=US/Central:20030210T090000
UID:BFA65BA2-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Motor Neuron Disorders
DTSTART;TZID=US/Central:20030210T100000
UID:BFA65F6F-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Peripheral Neuropathy
DTSTART;TZID=US/Central:20030210T110000
UID:BFA66350-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Biostatistics
DTSTART;TZID=US/Central:20030210T130000
UID:BFA66736-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path Lab II
DTEND;TZID=US/Central:20030212T100000
DTSTART;TZID=US/Central:20030212T080000
UID:BFA66B22-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Overview of Myopathies
DTSTART;TZID=US/Central:20030212T100000
UID:BFA66F11-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Neuropathology CNS Tumors & Neurocutaneous Syndromes
DTEND;TZID=US/Central:20030212T120000
DTSTART;TZID=US/Central:20030212T110000
UID:BFA6749A-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path Lab III
DTEND;TZID=US/Central:20030214T100000
DTSTART;TZID=US/Central:20030214T080000
UID:BFA678F3-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: Narcotic Analgesics & Narcotic Antagonists
DTSTART;TZID=US/Central:20030213T080000
UID:BFA67D18-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Non- Narcotic Analgesic Agents
DTSTART;TZID=US/Central:20030213T090000
UID:BFA680EE-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: An Integrated Approach to Pain Management
DTSTART;TZID=US/Central:20030214T100000
UID:BFA684F6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Cancer Pain Management
DTSTART;TZID=US/Central:20030214T110000
UID:BFA688D6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: General Anesthetic Agents
DTEND;TZID=US/Central:20030214T140000
DTSTART;TZID=US/Central:20030214T130000
UID:BFA68CAC-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: General Anesthetic Agents
DTSTART;TZID=US/Central:20030214T140000
UID:BFA6909A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: **Clinical Case \; ) **
DTSTART;TZID=US/Central:20030214T150000
UID:BFA6946E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Biostatistics
UID:BFA69841-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030218T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Biostatistics
UID:BFA69C37-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030319T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Ophthalmology Exam
DTSTART;TZID=US/Central:20030219T080000
UID:BFA6A03A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Common Ocular Disorders
DTSTART;TZID=US/Central:20030219T090000
UID:BFA6A410-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Diagnosis & Treatment of Red Eye
DTSTART;TZID=US/Central:20030219T100000
UID:BFA6A7E6-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Small Group
DTSTART;TZID=US/Central:20030219T130000
UID:BFA6AC02-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Musculoskeletal Radiology
DTSTART;TZID=US/Central:20030220T080000
UID:BFA6B018-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Common Orthopedic Problems in Peds
DTSTART;TZID=US/Central:20030220T090000
UID:BFA6B42F-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Osteoarthritis
DTSTART;TZID=US/Central:20030221T080000
UID:BFA6B840-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Pharm: NSAID's & Gout Drugs
DTSTART;TZID=US/Central:20030221T090000
UID:BFA6BC2E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Rheumatoid Arthritis
DTSTART;TZID=US/Central:20030221T100000
UID:BFA6C012-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Systemic Lupus Erythematosus
DTSTART;TZID=US/Central:20030221T110000
UID:BFA6C428-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Vasculitis
DTSTART;TZID=US/Central:20030221T130000
UID:BFA6C828-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Falls & Mobility in the Elderly
DTSTART;TZID=US/Central:20030221T140000
UID:BFA6CC30-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:CTRC
DTSTART;TZID=US/Central:20030218T080000
UID:BFA6D5CE-5047-11D7-83A9-00039357ED28-RID
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:President's Day: CTRC
DTEND;TZID=US/Central:20030217T170000
DTSTART;TZID=US/Central:20030217T080000
UID:BFA6DC19-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:CTRC
DTEND;TZID=US/Central:20030211T120000
UID:BFA6E046-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030211T080000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:CTRC
DTSTART;TZID=US/Central:20030204T080000
UID:BFA6E4B8-5047-11D7-83A9-00039357ED28-RID
DURATION:PT4H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Clinical Evaluation of the Spine
DTSTART;TZID=US/Central:20030224T080000
UID:BFA6E86A-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: The Upper Extremity
UID:BFA6EC6E-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030224T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Burns
DTSTART;TZID=US/Central:20030224T110000
UID:BFA6F08C-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: General Principles of Trauma Care
DTSTART;TZID=US/Central:20030224T130000
UID:BFA6F473-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Shock
DTSTART;TZID=US/Central:20030224T140000
UID:BFA6F84B-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Crystal-induced Arthritis/Infectious Arthritis
DTSTART;TZID=US/Central:20030225T080000
UID:BFA6FC4B-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Spondyloarthropathy
DTSTART;TZID=US/Central:20030225T090000
UID:BFA70048-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Assessing Elder Abuse
DTEND;TZID=US/Central:20030225T110000
DTSTART;TZID=US/Central:20030225T100000
UID:BFA7044C-5047-11D7-83A9-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Diseases of Joints
DTSTART;TZID=US/Central:20030225T110000
UID:BFA7083E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Bone Diseases
DTSTART;TZID=US/Central:20030225T130000
UID:BFA70C03-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Bone Tumors
DTEND;TZID=US/Central:20030225T150000
UID:BFA70FFE-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030225T140000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path: Soft Tissue Tumors
DTSTART;TZID=US/Central:20030226T080000
UID:BFA713EF-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Common Foot Problems
DTSTART;TZID=US/Central:20030226T090000
UID:BFA717EA-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path Lab
DTSTART;TZID=US/Central:20030226T100000
UID:BFA71C0D-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Child & Adolescent Physical Abuse
DTSTART;TZID=US/Central:20030226T130000
UID:BFA72020-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Sexual Abuse of Children
DTSTART;TZID=US/Central:20030226T140000
UID:BFA7241E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Case Conferences
DTSTART;TZID=US/Central:20030227T080000
UID:BFA72816-5047-11D7-83A9-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Social Pathology- Injuries
DTSTART;TZID=US/Central:20030227T100000
UID:BFA72C02-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ICS: Social Pathology- Childhood/Adolescent Poisoning
DTSTART;TZID=US/Central:20030227T110000
UID:BFA72FE4-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Neuro Module Exam
DTSTART;TZID=US/Central:20030305T090000
UID:BFA733D2-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Musculoskeletal Module Exam
DTSTART;TZID=US/Central:20030306T090000
UID:BFA737CC-5047-11D7-83A9-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Mini Step I (mandatory)
UID:BFA73BB8-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030211T130000
DURATION:PT3H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Third Year Clerkship Meeting
DTSTART;TZID=US/Central:20030325T100000
UID:BFA73F8D-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Mabee Conference Ctr: Glioblastoma Multiforme
DTSTART;TZID=US/Central:20030317T120000
UID:BFA74378-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Mabee Conference Ctr: Dose Escalation for Lung Cancer
DTSTART;TZID=US/Central:20030317T080000
UID:BFA74774-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:Path Survey available on-line
DTSTART;TZID=US/Central:20030227T120000
UID:BFA74B7E-5047-11D7-83A9-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025152Z
SUMMARY:ACES Lab: Musculoskeletal
UID:BFA74F97-5047-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030225T140000
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025844Z
SUMMARY:ICS: Labor & Delivery
UID:AB721427-5048-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030317T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025906Z
SUMMARY:ICS: Abnormal Labor
UID:BB4CFC50-5048-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030317T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025917Z
SUMMARY:ICS: Placenta
UID:C5BD7422-5048-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030317T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T025940Z
SUMMARY:Path: Disorders of Placenta
UID:CCC27706-5048-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030317T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030021Z
SUMMARY:Pharm: Estrogens & Progestins
UID:E8A0DDA2-5048-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030317T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030054Z
SUMMARY:Path: Corpus Uteri & Endometrium
UID:F7AFA304-5048-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030318T130000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030111Z
SUMMARY:ICS: Genetic Counseling & Ultrasound
UID:04F4BA2C-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030318T140000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030148Z
SUMMARY:ICS: Prenatal Diagnosis
DTEND;TZID=US/Central:20030318T160000
UID:0F2CE2A5-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030318T150000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030207Z
SUMMARY:ICS: Endocrinology of Pregnancy
UID:253A6F51-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030318T160000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030228Z
SUMMARY:ICS: Fetal Development & Physiology
UID:30776C18-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030319T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030245Z
SUMMARY:Path: Vulva & Vagina
UID:3D71BAFD-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030319T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030306Z
SUMMARY:Path: Uterine Cervix
UID:482E92AA-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030319T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T030326Z
SUMMARY:Path: Fallopian Tubes & Ovaries
UID:54366526-5049-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030319T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T032840Z
SUMMARY:Path: Fallopian Tubes & Ovaries
UID:D70EDCE2-504C-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030320T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T032931Z
SUMMARY:ICS: Gamete Transport\, In Vitro Fetrilization
UID:E42BBC11-504C-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030320T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T033031Z
SUMMARY:ICS: Fertilization & Implantation
DTEND;TZID=US/Central:20030321T090000
UID:054F57CD-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030321T080000
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T033046Z
SUMMARY:ICS: Embryology of the Reproductive System
UID:285737B0-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030321T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T033058Z
SUMMARY:ICS: Disorders of Sexual Cycle
UID:312A5FE8-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030321T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T033112Z
SUMMARY:ICS: Menstrual Cycle
UID:399EE700-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030321T110000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T033138Z
SUMMARY:ICS: Menstrual Abnormalities
UID:43FEC03F-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030324T080000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T033144Z
SUMMARY:ICS: Puberty
UID:4F27CF59-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030324T090000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030307T034523Z
SUMMARY:ICS: Delayed & Precocious Puberty
UID:534F0B2E-504D-11D7-83A9-00039357ED28-RID
DTSTART;TZID=US/Central:20030324T100000
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025329Z
SUMMARY:ICS: Hirsutism
DTSTART;TZID=US/Central:20030324T110000
UID:4A81E1FA-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025353Z
SUMMARY:ICS: PCO\, LOCAH\, Cushing's Dz
DTSTART;TZID=US/Central:20030324T130000
UID:4FF57E05-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025415Z
SUMMARY:ICS: Contraception & Pregnancy
DTSTART;TZID=US/Central:20030324T140000
UID:602C2D42-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025428Z
SUMMARY:ICS: Menopause
DTEND;TZID=US/Central:20030324T160000
DTSTART;TZID=US/Central:20030324T150000
UID:6BBB7452-51DA-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025453Z
SUMMARY:ICS: Hyperporlactinemia & Galactorrhea
DTSTART;TZID=US/Central:20030324T160000
UID:73A52AD6-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025553Z
SUMMARY:Path: Breast Dz
DTSTART;TZID=US/Central:20030326T080000
UID:8550218F-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025554Z
SUMMARY:ICS: Breast Cancer
DTSTART;TZID=US/Central:20030326T090000
UID:8D7262E1-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025625Z
SUMMARY:ICS: Normal & Abnormal Fetal Growth
DTSTART;TZID=US/Central:20030326T100000
UID:AEE60F49-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025656Z
SUMMARY:ICS: Postpartum Pd & Lactation
DTSTART;TZID=US/Central:20030326T110000
UID:BACAE294-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025707Z
SUMMARY:ICS: Adrenal Gland
DTSTART;TZID=US/Central:20030326T130000
UID:CB619424-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025730Z
SUMMARY:Path: Lab 1
DTSTART;TZID=US/Central:20030327T080000
UID:D58F05DC-51DA-11D7-B190-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025739Z
SUMMARY:ICS: Thyroid Gland
DTSTART;TZID=US/Central:20030328T080000
UID:DF657FC5-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025841Z
SUMMARY:Path: Thyroid: Pathology Features
DTSTART;TZID=US/Central:20030328T090000
UID:ED2623CA-51DA-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025916Z
SUMMARY:Pharm: Thyroid & Pituitary Drugs
DTSTART;TZID=US/Central:20030328T100000
UID:0B8CECB4-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025922Z
SUMMARY:Pharm: Thyroid & Pituitary Drugs
DTSTART;TZID=US/Central:20030328T110000
UID:1FBD0A1A-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T025937Z
SUMMARY:Biostatistics Answers Due
DTSTART;TZID=US/Central:20030328T170000
UID:25091E0E-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030000Z
SUMMARY:ICS: Pituitary Gland
DTSTART;TZID=US/Central:20030331T080000
UID:305B7342-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030018Z
SUMMARY:Path: Parathyroid & Adrenal Pathology
DTSTART;TZID=US/Central:20030331T090000
UID:3920E39C-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030048Z
SUMMARY:Pharm: Glucocorticoids- Steroids
DTSTART;TZID=US/Central:20030331T100000
UID:43409562-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030106Z
SUMMARY:ICS: Congenital Endocrine Problems
DTSTART;TZID=US/Central:20030331T110000
UID:55DB1366-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030133Z
SUMMARY:ICS: Adrenal/Thyroid Conference
DTEND;TZID=US/Central:20030401T100000
DTSTART;TZID=US/Central:20030401T080000
UID:60C88648-51DB-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030223Z
SUMMARY:Path: Pancreas Endocrine Path & Multiple Syndromes
DTSTART;TZID=US/Central:20030401T100000
UID:73299934-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030237Z
SUMMARY:ICS: Lipid Disorders in Diabetes
DTSTART;TZID=US/Central:20030401T110000
UID:8EAA5D7C-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030331Z
SUMMARY:Pharm: Pharmacology Review
DTEND;TZID=US/Central:20030401T150000
DTSTART;TZID=US/Central:20030401T130000
UID:A65858AE-51DB-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030400Z
SUMMARY:ICS: Diabetes Mellitus I
DTSTART;TZID=US/Central:20030402T080000
UID:BDBD2E72-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030407Z
SUMMARY:ICS: Diabetes Mellitus II
DTSTART;TZID=US/Central:20030402T090000
UID:C893F81F-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030507Z
SUMMARY:ICS: Growth & Development I
DTSTART;TZID=US/Central:20030402T100000
UID:E7024ED2-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030524Z
SUMMARY:ICS: Growth & Development I
DTSTART;TZID=US/Central:20030402T110000
UID:F81C4DC6-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030543Z
SUMMARY:Pharm: Pharmacology Review
DTSTART;TZID=US/Central:20030402T130000
UID:FEAA6936-51DB-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030752Z
SUMMARY:ICS: Diabetes in Pregnancy
DTSTART;TZID=US/Central:20030403T080000
UID:4A67EBD0-51DC-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030809Z
SUMMARY:ICS: Osteoporosis
DTSTART;TZID=US/Central:20030403T090000
UID:53674A21-51DC-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030829Z
SUMMARY:ICS: Diabetes in Pregnancy
DTSTART;TZID=US/Central:20030404T080000
UID:62253BEF-51DC-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030902Z
SUMMARY:ICS: Managing Pediatric Diabetes
DTEND;TZID=US/Central:20030404T100000
DTSTART;TZID=US/Central:20030404T090000
UID:6856C29C-51DC-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T030920Z
SUMMARY:ICS: Long Term Sequellae of Childhood Dz
DTSTART;TZID=US/Central:20030404T100000
UID:7C8BF960-51DC-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031052Z
SUMMARY:Pharm: Pharmacology Review
DTEND;TZID=US/Central:20030404T140000
DTSTART;TZID=US/Central:20030404T130000
UID:878F5BEF-51DC-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031054Z
SUMMARY:ICS: Foot Problems in Diabetes
DTSTART;TZID=US/Central:20030404T110000
UID:AB4FEB7C-51DC-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031250Z
SUMMARY:ICS: Pituitary/Calcium Conference
DTEND;TZID=US/Central:20030407T100000
DTSTART;TZID=US/Central:20030407T080000
UID:CD2B1E3C-51DC-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031246Z
SUMMARY:ICS: Diabetic Ketoacidosis
DTEND;TZID=US/Central:20030407T110000
DTSTART;TZID=US/Central:20030407T100000
UID:EC9B8800-51DC-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031415Z
SUMMARY:Pharm: Treatment of Diabetes Mellitus
DTSTART;TZID=US/Central:20030407T110000
UID:213D8EBA-51DD-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031427Z
SUMMARY:Path: Lab 2
DTSTART;TZID=US/Central:20030408T080000
UID:3749BCFE-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031444Z
SUMMARY:ICS: Diabetes Conference
DTSTART;TZID=US/Central:20030408T100000
UID:411A2832-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031543Z
SUMMARY:Pharm: Pharmacology Review
DTSTART;TZID=US/Central:20030408T130000
UID:5190CAC7-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031607Z
SUMMARY:Path: Pharmacology Review
DTSTART;TZID=US/Central:20030409T090000
UID:6A6FF87F-51DD-11D7-B190-00039357ED28-RID
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031622Z
SUMMARY:Path: Biostatistics
DTSTART;TZID=US/Central:20030409T130000
UID:7967D84E-51DD-11D7-B190-00039357ED28-RID
DURATION:PT1H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031651Z
SUMMARY:Pharm: Pharmacology Review
DTSTART;TZID=US/Central:20030410T080000
UID:82F5195C-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031722Z
SUMMARY:Pharm: Pharmacology Review
DTSTART;TZID=US/Central:20030411T080000
UID:A13D3D1C-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031758Z
SUMMARY:Endocrine Module Exam
DTSTART;TZID=US/Central:20030416T090000
UID:B2C6AFE4-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031821Z
SUMMARY:Reproductive Module Exam
DTEND;TZID=US/Central:20030418T114500
DTSTART;TZID=US/Central:20030418T090000
UID:BC156A19-51DD-11D7-B190-00039357ED28-RID
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031936Z
SUMMARY:Pharmacology Final Exam
DTSTART;TZID=US/Central:20030422T090000
UID:D19219E0-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T031946Z
SUMMARY:Pathology Final Exam
DTSTART;TZID=US/Central:20030424T090000
UID:F79ACC11-51DD-11D7-B190-00039357ED28-RID
DURATION:PT2H45M
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T032453Z
SUMMARY:Aces Lab: Groups 1-3
UID:A6BB642E-51DE-11D7-9B1F-00039357ED28-RID
DTSTART;TZID=US/Central:20030331T140000
DURATION:PT3H
END:VEVENT
BEGIN:VEVENT
DTSTAMP:20030309T032618Z
SUMMARY:ACES 7th H&P Due
UID:DE57BBD8-51DE-11D7-9B1F-00039357ED28-RID
DTSTART;TZID=US/Central:20030328T160000
DURATION:PT1H
END:VEVENT
END:VCALENDAR